| Glenmark gets $15 mln from Forest
Labs NEW DELHI, Feb 6: Glenmark Pharmaceuticals Ltd today said its Swiss subsidiary has received a payment of 15 million dollars from US-based Forest Labs, ......more' MRPL & Shell enters Joint Venture in Aviation Fuelling Business MUMBAI, Feb 6: Mangalore Refinery & Petrochemicals Ltd (MRPL) has announced that the Company and a subsidiary of ONGC, ....more NEW DELHI, Feb 6: To strengthen its presence in the US retail markets, Natco Pharma Ltd today said it has acquired US-based retail pharmacy stores Newark Drugs."U......more US economy decline will not have impact on SAP: Ranjan Das BANGALORE, Feb 6: President and CEO of SAP, worlds leading provider of business software Ranjan Das today opined that the fall in US economy will not have any adverse impact on SAP India , .....more |
|
Indiabulls Financial to raise up to
Rs 4,000 cr MUMBAI, Feb 6: Domestic brokerage major Indiabulls Financial Services today said it will raise funds to the tune of Rs 4,000 crore through the issue of securities .....more Further fall in Instanex Skindia DR Index MUMBAI, Feb 6: The Instanex Skindia DR Index declined further by 45.51 points or 1.44 per cent to 3,104.12 on February 5 from 3,149.63 previously.......more GoAir launches new fare plan, removes rescheduling charge MUMBAI, Feb 6: Wadias-promoted budget carrier GoAir today launched a new fare plan having lower cancellation charges .....more NEW DELHI, Feb 6: Chemical prices moved in a tight range in the wholesale chemical market today and closed around previous levels.Traders said negligible enquiries from consuming industries against adequate stocks ....more |
Glenmark gets $15 mln from Forest Labs NEW DELHI, Feb 6: Glenmark Pharmaceuticals Ltd today said its Swiss subsidiary has received a payment of 15 million dollars from US-based Forest Labs, for its experimental Oglemilast molecule. Glenmark and Forest Labs are working together closely to initiate additional studies for further long term development of oglemilast, including a Phase II study in Asthma, according to a company statement. Both the companies had entered into a collaborative agreement in September 2004, wherein Forest will develop, register and commercialise GRC 3886 for the North American market, while Glenmark will retain commercialisation rights for the rest of the world. Forest paid Glenmark an up-front payment upon initiation of the agreement, and will pay more if the development and commercialisation of the product is successfully completed in the North American market; the total value of these payments could be 190 million dollars, the statement added. The payment followed the US Food and Drug Administration approval to start additional phase II, or mid-stage, clinical studies on the molecule for a host of lung disorders. Mumbai-based Glenmark has a similar deal with Teijin Pharma Ltd for the region of Japan. (UNI) MRPL & Shell enters Joint Venture in Aviation Fuelling Business MUMBAI, Feb 6: Mangalore Refinery & Petrochemicals Ltd (MRPL) has announced that the Company and a subsidiary of ONGC, has entered into an agreement to form a Joint Venture with Shell for domestic marketing of Aviation Fuel. The Joint Venture (JV) was signed on February 05 by MRPL Managing Director R Rajamani and Vice President Shell Aviation Sjoerd Post, in the presence of Chairman ONGC Group of Companies R S Sharma and Chairman Shell Group of Companies in India Vikram S Mehta. The agreement is effective from March 01, 2008, the company's release at BSE, stated here today. The JV Company would be incorporated as a private limited Company, with initial equity of Rs 30 Crores. The Registered and Head offices of the JV would be at Bangalore. JV will initially commence marketing of ATF at Bangalore and Hyderabad, and later expand its operations to other airports in India. JV will refuel foreign aircrafts in Indian airports and will also contract refuelling of Indian aircrafts at foreign airports through Shell affiliates. Mr Sharma was optimistic that the JV agreement as a major initiative by both Companies to cater the growing Indian Aviation sector that will catalyse the marketing activities of MRPL. Mr Mehta said, ''With huge growth in the civil aviation sector in India, it is indeed timely that we are formally joining hands with MRPL, to serve this large market opportunity with our shared values of quality products and excellent service.'' (UNI) NEW DELHI, Feb 6: To strengthen its presence in the US retail markets, Natco Pharma Ltd today said it has acquired US-based retail pharmacy stores Newark Drugs. "US-based general partnership firm K&C Pharmacy, in which Natco has stake of 75 per cent, has acquired Network Drugs," a company statement said. Newark Drugs annual sales stands at about five million dollars. Through this acquisition, Natco seeks to achieve economics of scale in purchasing and its revenues from the US retail aggregates to over 35 million dollars annually. The company plans to acquire a few more stores to strengthen its presence in the US retail markets, the statement added. Since 2006, this is the third acquisition by Natco, after Nicks Drugs and SaveMart Drugs. (UNI) |
US economy decline will not have impact on SAP: Ranjan Das BANGALORE, Feb 6: President and CEO of SAP, worlds leading provider of business software Ranjan Das today opined that the fall in US economy will not have any adverse impact on SAP India and there will be no cut in expenditure cost or cut in jobs. Talking to newspersons here, he said "there may not be any impact on SAP following decline in the US economy and in India I dont expect slow down." Mr Das said SAP India has registered over 100 per cent growth in license revenue in 2007 as compared to previous year and the number of customers has doubled to 3,024 from 1,350 in December 2006. Business also registered a 230 per cent growth and SAPs market share in terms of revenue stood at 42.5 per cent. Mr Das said the company plans to launch Buy Back product aimed at garnering small companies in April this year. Replying to a question, he said the process of SAP investing One Billion dollar by 2010, started in 2006 is continuing. With the company registering overwhelming growth, SAP will go in for recruitment drive this year and more than 100 might be recruited. India is the third largest subsidiary for SAP in terms of employees. At present SAP has 4,836 employees on its roll, he said. SAP India has direct presence in nine cities besides Sri Lanka and Bangladesh. (UNI) Indiabulls Financial to raise up to Rs 4,000 cr MUMBAI, Feb 6: Domestic brokerage major Indiabulls Financial Services today said it will raise funds to the tune of Rs 4,000 crore through the issue of securities in domestic as well as international markets. The company would raise Rs 4,000 crore in one or more tranches through the issue of Foreign Currency Convertible Bonds, Global Depository Receipts, equity shares, debentures or any other securities other than warrants to Qualified Institutional Buyers (QIB), Indiabulls Financial said in a filing to the Bombay Stock Exchange. Indiabulls Financial would also enhance the existing borrowing limits and increase the existing authorised share capital of the company. The board of directors have approved the draft postal ballot notice covering the aforesaid matters and the company would seek shareholders approval for the above mentioned purposes through postal ballot. The results of the postal ballot would be declared on March 6, this year. Earlier in January this year, the board of directors approved the proposal to raise 1 billion dollar (about Rs 4,000 crore) through the issue of shares by international offerings of convertible securities such as American Depository Receipts (ADRs), GDRs and FCCBs convertible into equity shares. (PTI) |
Further fall in Instanex Skindia DR Index MUMBAI, Feb 6: The Instanex Skindia DR Index declined further by 45.51 points or 1.44 per cent to 3,104.12 on February 5 from 3,149.63 previously. However, the P/E Ratio ruled steady at 26.77 Instanex Capital release said here today. Following are the GDR and ADR rates for Feb 5 in US dollars with differences in percentage from the previous level given in brackets. Bajaj Auto(GDR) 61.50 (-0.76) Dr Reddy (ADR) 13.85 (+0.80) HDFC Bank (ADR) 110.89 (-5.54) Hindalco (GDR) 4.60 (+1.32) ICICI Bank (ADR) 57.74 (-4.47) Infosys Tech (ADR) 39.85 (-6.65) ITC (GDR) 5.24 (+6.07) L&T (GDR) 95.95 (+2.62) MTNL (ADR) 6.52 (-5.23) Ranbaxy Labs (GDR) 9.70 (+7.78) Reliance (GDR) 130.70 (+5.70) Satyam Comp (ADR) 24.34 (-6.46) SBI (GDR) 113.50 (-2.99) VSNL (ADR) 25.01 (-6.85) Wipro (ADR) 11.92 (-6.22) (PTI) |
GoAir launches new fare plan, removes rescheduling charge MUMBAI, Feb 6: Wadias-promoted budget carrier GoAir today launched a new fare plan having lower cancellation charges and no rescheduling fees, which the company expects will contribute about 10 per cent to its revenue this year. The new plan, named GoFlexi Fare, would be available on all its routes, GoAir Managing Director Jeh Wadia said in a statement. Under the new plan, the passenger would be able to make unlimited changes in its travel itinerary free of cost. Besides, GoAir has cut the cancellation changes to Rs 200 on all GoFlexi bookings. According to analysts covering aviation sector, with the new plan GoAir is seeking a competitive edge over other low-cost airlines, who levy rescheduling and cancellation charges of Rs 500-750 on their passengers. This might lead to similar or other competitively priced plans by its rivals as well, they said. The analysts said GoAir is targeting frequent-flying business passengers, such as traders and executives, with the new plan. It is not the leisure travellers or occasion-flying customers making frequent changes to their schedule, but the frequent fliers who bring in bigger chunk of revenue for airlines and hence the strategy could help GoAir, they said. GoAir said it expects GoFlexi Fares to contribute 10 per cent revenue growth during the current year. "Our GoFlexi Fare is aimed at providing passengers the flexibility to modify their travel itinerary as per their individual needs without burdening their budgetary allocations," Wadia said. (PTI) |
|
|||||
|
|||||
|